The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Search articles by EPIC code

Woodford – selling BTG but all is surely not clear (apart from the cash-crisis!)

2018-12-09 01:42:58

We have commented here on ShareProphets on the recent sales of shares in BTG (BTG) by Neil Woodford’s Woodford Investment Management. Given that BTG is the subject of a cash offer of 840p per share is seems a little odd that he is offloading stock before the offer completes, especially with the shares trading at around  825p – but then, he does have some pressing cash issues of his own. But what is even more odd is his irrevocable undertaking to accept the offer, for it appears to have been given over a rather small portion of the shares he was actually holding.


Just how desperate for cash is Neil Woodford – another telling announcement: BTG

2018-12-05 02:08:04

After recent disasters such as Kier (KIE) and faced with wall to wall redemptions, funds managed by Neil “nomates” Woodford are clearly utterly desperate for cash. Today another sign of just how big is that crisis emerged. It’s a shocker.


Zak Mir's Bear Call Of The Day: BTG: Further Declines Towards 600p

2015-07-16 00:31:40

Having been a fan of the rally served up by BTG (BTG) shares in H2 2014, from the summer towards the end of the year, 600p – 800p, the present charting set up is all the more disappointing.


Zak Mir's Bear Call Of The Day: BTG: Risk Of Impulsive Move To Below 600p

2015-06-02 23:53:36

While there is always the risk of some M&A action to spoil the bear idea on a technical basis for technical traders at BTG, as things stand this looks to be a bona fide sell opportunity.


Zak Mir's Bear Call Of The Day: BTG Bull Trap Reversal Targets Back To 600p

2015-05-20 02:46:43

One of the more difficult things to do when it comes to trading either fundamentally or technically is to call time on an extended uptrend. This is what shares of BTG have served up over the two years leading into January this year. 


BTG at 382.5p is worth 516p says Edison

2013-07-24 11:25:08

Commissioned researcher Edison has published a detailed buy note on biotech mid-cap BTG (BTG) in which it tweaks its models upwards. The report asserts that BTG is both a beneficiary (Zytiga sales growth) and casualty (brachytherapy sales decline) of the changing treatment landscape for metastatic prostate cancer (mCRPC).

Search ShareProphets |

Recent Comments |

About ShareProphets

Contact Us

Advertise With Us

Send Us A Tip


Terms of Service

Privacy Policy

Cookie Policy

Forgot My Password

Forgot My Username

Resend Account Validation Token

Site by Everywhen